Which insiders are buying Novartis AG (NVS)?

Novartis AG (NYSE:NVS) marched up -0.3% compared to a 52-week low price of $73.79. The shares were last seen trading -0.7% lower, taking the closing price at $73.57 on 06/19/2018. At recent session, the prices were hovering between $73.21 and $73.89. This company shares are 19.83% off its target price of $88.16 and the current market capitalization stands at $187.51B. The recent change has given its price a -4.74% deficit over SMA 50 and -21.89% deficit over its 52-week high. The stock witnessed -4.53% declines, -9.55% declines and -13.3% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found NVS’s volatility during a week at 0.75% and during a month it has been found around 0.94%.

Novartis AG (NVS) Top Holders

Institutional investors currently hold around $19.25 billion or 11.4% in NVS stock. Look at its top three institutional owners. Dodge & Cox owns $3.28 billion in Novartis AG, which represents roughly 1.75% of the company’s market cap and approximately 17.05% of the institutional ownership. Similar statistics are true for the second largest owner, Primecap Management Co/Ca/, which owns 21,818,472 shares of the stock are valued at $1.62 billion. The third largest holder is Franklin Resources Inc, which currently holds $1.1 billion worth of this stock and that ownership represents nearly 0.58% of its market capitalization.

Novartis AG 13F Filings

At the end of March reporting period, 442 institutional holders increased their position in Novartis AG (NYSE:NVS) by some 11,467,593 shares, 446 decreased positions by 7,292,191 and 182 held positions by 241,011,439. That puts total institutional holdings at 259,771,223 shares, according to SEC filings. The stock grabbed 77 new institutional investments totaling 2,399,489 shares while 62 institutional investors sold out their entire positions totaling 814,186 shares.

Novartis AG (NVS) Analyst Guide

Several analysts have released their opinion on Novartis AG (NYSE:NVS), with 2 analysts believing it is a strong buy. Whereas 1 of them predict the stock is a hold. Also, there are 0 buy, 1 sell and 1 strong sell ratings, collectively assigning a 2.8 average brokerage recommendation.